not losing weight on semaglutides Compounded semaglutide working? lack of energy on semaglutide

SAXENDA was evaluated for safety in 5 double-blind, placebo controlled trials that included 3,384 overweight or obese adult patients treated with SAXENDA for a treatment period up to 56 weeks (3 trials), 52 weeks (1 trial), and 32 weeks (1 trial) and one trial of 56 weeks in 125 pediatric patients with obesity aged 12 years and older [see Clinical Studies (14.1, 14.2)]

Most weight management medications may lead to gastrointestinal disturbances such as nausea, diarrhea, constipation, and abdominal pain

This amount varies tremendously depending where you live and your lifestyle

Until Phase 3 data are available, and particularly until head-to-head comparisons and cardiovascular outcomes trials are completed, retatrutide's apparent advantages remain preliminary and unconfirmed

in StatPearls (2024)

You dont pay unless we win